Simon P. Kim, MD (Oncology: Genitourinary Cancer)

Division of Urology, University of Colorado Anschutz Medical Center, Aurora, CO, USA

Dr. Simon Kim is a board-certified urologic oncologist at the University of Colorado-Denver Medical Campus. His clinical practice focuses on the surgical management of genitourinary malignancies. He specializes in the surgical treatment of bladder, kidney, prostate, testis, adrenal and penile cancer. He performs robotic, laparoscopic and open surgery for localized or locally advanced cancers. He previously served as a Director of Robotic Surgery and Director of Kidney and Bladder Cancer at his previous faculty appointment. He was recently appointed as Associate Program Director for the Urology Residency at the University of Colorado.

Dr. Kim’s research focuses on improving the quality of care and health outcomes for patients diagnosed with prostate, bladder and kidney cancer. He also has research interests in shared decision-making and health services research. Dr. Kim was awarded a career development award from the Conquer Cancer Foundation of the American Society of Clinical Oncology. He has been independently funded from the NIH to develop decision aids for men diagnosed with localized prostate cancer. He has published more than 180 manuscripts in outcomes research for genitourinary cancer and was awarded the Journal of Urology Best Reviewer Award in 2013. He currently serves as the Assistant Editor for the Journal of Urology as well as a reviewer for many cancer, surgery and urology journals. Dr. Kim was a former Director of Robotic Surgery and Director of Kidney and Bladder Cancer in Cleveland.

His clinical interest is focused on developing individualized treatment plans for patients diagnosed with genitourinary malignancies (prostate, kidney, bladder, testicular, adrenal and penile cancer) to achieve the possible outcomes. His clinical work focuses on open and minimally invasive surgery (laparoscopy and robotics), nephron-preserving renal surgery, IVC tumor thrombus as well as, robotic and open prostatectomy and cystectomy.

His research interests are primarily focused on shared decision-making, quality of care, outcomes research and survey research in genitourinary malignancies. He has developed decision aids to improve patient communication when confronted with difficult treatment decision, such as prostate cancer screening and treatment. He also focuses assessing and evaluating large data to identify ways we can improve outcomes and the quality of care for surgical patients diagnosed with prostate, bladder and kidney cancer. He has been externally funded for a career development award from the Conquer Cancer Foundation and American Society of Clinical Oncology (ASCO). He is currently funded as a co-principal investigator for an R01 grant from the NCI for an R01 grant to develop decision aids for men diagnosed with prostate cancer.

Editorial Board
Terms of Appointment: September 2019 - March 2022;  April 2022 - March 2024